Publication: 2850

Publication: 2850

Phase 2 multicentre study of single-agent ofatumumab in previously untreated follicular lymphoma: CALGB 50901 (Alliance)

PubMed

PMC

QxMD

DOI

Google Scholar

Citation:: Br J Haematol vol 185 (1) 53-64

Year:: 2019
Type:: Manuscript
Funding:: NCTN
Endpoint:: Primary
Analysis:: Primary
Data Sharing:: No-Data-Sharing
Status:: Presented/Published
Citation Status:: pmc-release

Note:

Methodological:: No
Biospecimen:: No
SDC:: No
Book Volume:: 8

Parents:: 2391
Children:: None

Program:: OGC
Primary Committee:: Lymphoma
Sec. Committees:

Pharmas:: GSK(Novartis)
Grants:: U10CA180821, U10CA180882, U10CA180833, U10CA180836, U10CA180857, UG1CA189830

Corr. Author:
Authors:: Cara A. Rosenbaum Sin-Ho Jung Brandelyn Pitcher Nancy L. Bartlett Sonali M. Smith Eric Hsi Nina Wagner-Johnston Sachdev P. Thomas John P. Leonard Bruce D. Cheson

Networks:: CAPITAL, KAISER, LAPS-IL057, LAPS-MD017, LAPS-MN026, LAPS-MO011, NY018

Study: CALGB-50901
Multiple Studies, or Legacy Studies in Alliance Study:
Phases:: 2

Keywords:: follicular lymphoma, previously untreated, immunotherapy, monoclonal antibody, ofatumumab